Cepham’s Luteye Centers on Cellular Senescence to Protect Aging Eyes
May 01, 2024 08:30 ET
|
Cepham
Cepham announces the launch of Luteye to combat the effects of aging on eyes.
Accounting for the Role of Gender is Critical to Maximizing Philanthropic Impact, According to Study
April 24, 2024 12:03 ET
|
The Bridgespan Group
BOSTON, April 24, 2024 (GLOBE NEWSWIRE) -- A new report by The Bridgespan Group, Illuminating Impact: Why Gender Matters for Funders in Any Issue Area, looks at the ways that considering gender in...
Progress Over Easy: Vital Farms Celebrates Continued Improvements to the Lives of People, Animals, and the Planet in 2024 Impact Update
March 14, 2024 08:00 ET
|
Vital Farms
AUSTIN, Texas, March 14, 2024 (GLOBE NEWSWIRE) -- Vital Farms (Nasdaq: VITL) today published its 2024 Impact Update, which recognizes the progress the company has made to continue building a...
Digital Science announces Catalyst Grant winners, supporting AI-based innovations to benefit research
February 29, 2024 07:00 ET
|
Digital Science
Digital Science has awarded two new Catalyst Grants of £25,000 each to innovative AI-based technology ideas aimed at advancing global research.
Bitcoin Well Provides Preliminary Year End Update and Bitcoin Super Company Vision
February 21, 2024 08:35 ET
|
Bitcoin Well
Preliminary, unaudited Q4 growth numbers for Bitcoin Well and Bitcoin Super Company vision outline.
ONL Therapeutics to Present at 2024 BIO CEO & Investor Conference
February 06, 2024 07:00 ET
|
ONL Therapeutics
ANN ARBOR, Mich., Feb. 06, 2024 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
Greif Announces New Partnership with the Columbus Blue Jackets NHL Franchise
February 02, 2024 10:30 ET
|
Greif Inc
Greif is proud to announce an exciting new partnership with the Columbus Blue Jackets NHL Franchise, extending through 2026.
New long-term data for Roche’s Vabysmo show sustained retinal drying and vision improvements in retinal vein occlusion (RVO)
February 01, 2024 01:03 ET
|
F. Hoffmann-La Roche Ltd
Vabysmo sustained robust drying of retinal fluid, often associated with distorted or blurry vision Up to 60% of people receiving Vabysmo were able to extend treatment intervals to three or four months...
ONL Therapeutics to Present on ONL1204 in Podium Presentation at the 47th Annual Meeting of the Macula Society
January 23, 2024 07:00 ET
|
ONL Therapeutics
ANN ARBOR, Mich., Jan. 23, 2024 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
Morgan Gustafson Promoted to Jr. Art Director at Hummingbird Creative Group
January 16, 2024 15:37 ET
|
Hummingbird Creative Group
Cary, North Carolina, USA, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Hummingbird Creative Group, a brand strategy and creative agency in Cary, North Carolina, announced the promotion of Morgan Gustafson to...